anmelden
OMX Nordic 40
2.616,70
PKT
+0,46
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.04.16 | Nokia buy | UBS AG | |
| 15.04.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 14.04.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 13.04.16 | Nokia overweight | JP Morgan Chase & Co. | |
| 12.04.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.04.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 11.04.16 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 07.04.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 06.04.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 01.04.16 | Volvo (B) Equal-Weight | Morgan Stanley | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.03.16 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.03.16 | AstraZeneca buy | UBS AG | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 22.03.16 | AstraZeneca Hold | HSBC | |
| 22.03.16 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.03.16 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 16.03.16 | Nokia buy | Kepler Cheuvreux | |
| 16.03.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 15.03.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.03.16 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 09.03.16 | AstraZeneca overweight | Morgan Stanley | |
| 09.03.16 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk Sell | UBS AG | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 04.03.16 | ABB (Asea Brown Boveri) Reduce | Nomura | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.03.16 | Volvo (B) buy | HSBC | |
| 01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 29.02.16 | Nokia buy | Deutsche Bank AG |